Clincosm LogoSign in Get a demo

Advanced Cancer

Showing NaN - NaN of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Philadelphia, Pennsylvania
  • +4 more
Oct 12, 2020

Advanced Cancer Trial in Aurora, Rochester, Nashville (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Docetaxel, mitotic inhibitor;

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • +2 more
  • Aurora, Colorado
  • +2 more
Oct 2, 2020

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Cancer Trial in United States (Taladegib)

Completed
Has Results
  • Advanced Cancer
  • Scottsdale, Arizona
  • +11 more
Aug 7, 2019

Advanced Cancer Trial in Oklahoma City, Nashville (LY900009 - Dose Escalation Phase (Part A), LY900009 - Dose Confirmation Phase

Completed
Has Results
  • Advanced Cancer
  • LY900009 - Dose Escalation Phase (Part A)
  • LY900009 - Dose Confirmation Phase (Part B)
  • Oklahoma City, Oklahoma
  • +1 more
Jun 27, 2019

Advanced Cancer Trial in Boston, Portland, Nashville (CDX-0158 (formerly known as KTN-0158))

Completed
  • Advanced Cancer
  • CDX-0158 (formerly known as KTN-0158)
  • Boston, Massachusetts
  • +3 more
Jun 11, 2019

Advanced Cancer Trial in United States (LY2495655)

Completed
Has Results
  • Advanced Cancer
  • Scottsdale, Arizona
  • +6 more
Jan 4, 2019

Advanced Cancer Trial in Tampa, Nashville (LY2090314, pemetrexed, Carboplatin)

Completed
Has Results
  • Advanced Cancer
  • Tampa, Florida
  • +1 more
Oct 17, 2018

Advanced Cancer, Metastatic Cancer, Colorectal Cancer Trial in Charlotte, Nashville, Köln (prexasertib, ralimetinib)

Completed
  • Advanced Cancer
  • +3 more
  • Charlotte, North Carolina
  • +2 more
Dec 12, 2018

Advanced Cancer Trial in Nashville, San Antonio (pegfilgrastim, LY2523355)

Completed
Has Results
  • Advanced Cancer
  • Nashville, Tennessee
  • +1 more
Aug 3, 2018

Advanced Cancer Trial in United States (JNJ-61610588)

Terminated
  • Advanced Cancer
  • New York, New York
  • +3 more
Mar 26, 2018

Solid Tumor, Hodgkin's Lymphoma, NHL (Non-Hodgkin Lymphoma) Trial in Atlanta, Nashville, Dallas (INCB047986, Gemcitabine,

Terminated
  • Solid Tumor
  • +7 more
  • Atlanta, Georgia
  • +2 more
Jan 15, 2018

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Baltimore, Nashville (INCB028060)

Completed
  • Solid Tumor
  • +2 more
  • Baltimore, Maryland
  • +1 more
Nov 20, 2017

Advanced Cancer Trial in United States (KTN3379)

Completed
  • Advanced Cancer
  • KTN3379
  • Denver, Colorado
  • +4 more
Jul 21, 2017

Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck Trial in United States (Prexasertib)

Completed
  • Advanced Cancer
  • +5 more
  • Sarasota, Florida
  • +4 more
May 9, 2016

Advanced Cancer Trial in Sarasota, Boston, Nashville (OPB-51602)

Completed
  • Advanced Cancer
  • Sarasota, Florida
  • +2 more
Jan 14, 2014

Advanced Cancer, Solid Tumor Trial in Nashville, Houston (OPB-31121)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Nashville, Tennessee
  • +1 more
Feb 11, 2013

Advanced Cancer, Pancreatic Cancer Trial in United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Gemcitabine, nucleoside

Completed
  • Advanced Cancer
  • Pancreatic Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Gemcitabine, nucleoside analogue; intravenous
  • Phoenix, Arizona
  • +5 more
Sep 28, 2012

Advanced Cancer Trial in Santa Monica, Nashville (SGX523 Capsules)

Terminated
  • Advanced Cancer
  • SGX523 Capsules
  • Santa Monica, California
  • +1 more
Jul 22, 2008